• Fiorillo MT, Haroon N, Ciccia F, Breban M. Editorial: Ankylosing Spondylitis and Related Immune-Mediated Disorders. Front Immunol. 2019 Jun 4;10:1232. doi: 10.3389/fimmu.2019.01232. eCollection 2019.

  • Sari I, Haroon N. Disease modification in axial spondyloarthritis. Best Pract Res Clin Rheumatol. 2018 Jun;32(3):427-439.

  • Poddubnyy D, Haroon N. Recent advances in spondyloarthritis. Best Pract Res Clin Rheumatol. 2018 Jun;32(3):329-330.

  • Passalent L, Hawke C, Lawson D, Omar A, Alnaqbi K, Wallis D, Steinhart H, Silverberg M, Wolman S, Derzko-Dzulynsky L, Haroon N, Inman RD. Advancing early identification of axial spondyloarthritis: An interobserver comparison of extended role practitioners and rheumatologists. J Rheumatol. 2019 May 1. pii: jrheum.180787. doi: 10.3899/jrheum.180787. [Epub ahead of print]

  • Deodhar A, Gensler LS, Kay J, Maksymowych WP, Haroon N, Landewé R, Rudwaleit M, Hall S, Bauer L, Hoepken B, de Peyrecave N, Kilgallen B, van der Heijde D. A Fifty-Two-Week, Randomized, Placebo-Controlled Trial of Certolizumab Pegol in Nonradiographic Axial Spondyloarthritis. Arthritis Rheumatol. 2019 Jul;71(7):1101-1111.

  • Haroon N. Thinking Positive in Spondyloarthritis. Arthritis Rheumatol. 2019 Jun; 71(6):839-841

  • Sari I, Haroon N. Radiographic Progression in Ankylosing Spondylitis: From Prognostication to Disease Modification. Curr Rheumatol Rep. 2018 Nov8;20(12):82.

  • Lories RJ, Haroon N. Evolving concepts of new bone formation in axial spondyloarthritis: Insights from animal models and human studies. Best Pract Res Clin Rheumatol. 2017 Dec;31(6):877-886.

  • Nakamura A, Rampersaud YR, Nakamura S, Sharma A, Zeng F, Rossomacha E, Ali SA, Krawetz R, Haroon N, Perruccio AV, Mahomed NN, Gandhi R, Rockel JS, Kapoor M. microRNA-181a-5p antisense oligonucleotides attenuate osteoarthritis in facet and knee joints. Ann Rheum Dis. 2019 Jan;78(1):111-121.

  • Ciccia F, Guggino G, Zeng M, Thomas R, Ranganathan V, Rahman A, Alessandro R, Rizzo A, Saieva L, Macaluso F, Peralta S, Di Liberto D, Dieli F, Cipriani P, Giacomelli R, Baeten D, Haroon N. Pro-inflammatory CX3CR1(+) CD59(+) TL1A(+) IL-23(+) monocytes are expanded in patients with Ankylosing Spondylitis and modulate ILC3 immune functions. Arthritis Rheumatol. 2018;70(12):2003-2013. Senior Responsible Author.

  • Lories RJ, Haroon N. Evolving concepts of new bone formation in axial spondyloarthritis: Insights from animal models and human studies. Best Pract Res Clin Rheumatol. 2017 Dec;31(6):877-886. doi: 10.1016/j.berh.2018.07.007. Epub2018 Sep 20. Review. PubMed PMID: 30509446.

  • Sari I, Haroon N. Radiographic Progression in Ankylosing Spondylitis: From Prognostication to Disease Modification. Curr Rheumatol Rep. 2018 Nov 8;20(12):82. doi: 10.1007/s11926-018-0795-4. Review. PubMed PMID: 30406859.

  • Nakamura A, Rampersaud YR, Nakamura S, Sharma A, Zeng F, Rossomacha E, Ali SA, Krawetz R, Haroon N, Perruccio AV, Mahomed NN, Gandhi R, Rockel JS, Kapoor M. microRNA-181a-5p antisense oligonucleotides attenuate osteoarthritis in facet and knee joints. Ann Rheum Dis. 2019 Jan;78(1):111-121. doi:10.1136/annrheumdis-2018-213629. Epub 2018 Oct 4. PubMed PMID: 30287418.

  • Feld J, Chandran V, Haroon N, Inman R, Gladman D. Axial disease in psoriatic arthritis and ankylosing spondylitis: a critical comparison. Nat Rev Rheumatol. 2018 Jun;14(6):363-371. Coauthor or Collaborator.

  • Richard N, Hazel EM, Haroon N, Inman RD. Simultaneous inhibition of α4/β7 integrin and tumour necrosis factor-α in concomitant spondyloarthritis and inflammatory bowel disease. Ann Rheum Dis. 2017 Dec 29. pii: annrheumdis-2017-212819. . Coauthor or Collaborator.

  • Alazmi M, Sari I, Krishnan B, Inman RD, Haroon N. Profiling Response to TNF-Inhibitor Treatment in Axial Spondyloarthritis. Arthritis Care Res (Hoboken). 2017 Nov 10. Impact Factor 3.319. Senior Responsible Author.

  • Omar A, Sari I, Bedaiwi M, Salonen D, Haroon N, Inman RD. Analysis of dedicated sacroiliac views to improve reliability of conventional pelvic radiographs. Rheumatology (Oxford). 2017 Oct 1;56(10):1740-1745. Coauthor or Collaborator.

  • Ranganathan V, Ciccia F, Zeng F, Sari I, Guggino G, Muralitharan J, Gracey E, Haroon N. Macrophage Migration Inhibitory Factor Induces Inflammation and Predicts Spinal Progression in Ankylosing Spondylitis. Arthritis Rheumatol. 2017 Sep;69(9):1796-1806. Senior Responsible Author.

  • Ranganathan V, Gracey E, Brown MA, Inman RD, Haroon N. Pathogenesis of ankylosing spondylitis – recent advances and future directions. Nat Rev Rheumatol. 2017 Jun;13(6):359-367. Senior Responsible Author.

  • Zhang Z, Ciccia F, Zeng F, Guggino G, Yee K, Abdullah H, Silverberg MS, Alessandro R, Triolo G, Haroon N. Functional interaction of ERAP2 and HLA-B27 activates the unfolded protein response. Arthritis Rheumatol. 2017 May;69(5):1009-1015. Senior Responsible Author.

  • Chan J, Sari I, Salonen D, Inman RD, Haroon N. Development of a Screening Tool for the Identification of Sacroiliitis in Computed Tomography Scans of the Abdomen. J Rheumatol. 2016 Sep;43(9):1687-94. Senior Responsible Author.

  • Chan J, Sari I, Salonen D, Silverberg MS, Haroon N, Inman RD. Prevalence of Sacroiliitis in Inflammatory Bowel Disease Using a Standardized CT ScoringSystem. Arthritis Care Res (Hoboken). 2017 Jul 21. doi: 10.1002/acr.23323. [Epub ahead of print]

  • Sari I, Haroon N. Axial SpA: the recurrence plot thickens. Arthritis Rheumatol. 2016; Oct;68(10):2354-6. Senior Responsible Author.

  • Ciccia F, Haroon N. Autophagy in the pathogenesis of ankylosing spondylitis. Clin Rheumatol. 2016 Jun 1;35(6):1433-6. Senior Responsible Author.

  • Chan J, Sari I, Haroon N. Sacroiliitis-like Changes in 2 Patients with Spina Bifida. J Rheumatol. 2016 Mar 1;43(3):673. Senior Responsible Author.

  • Bedaiwi M, Sari I, Thavaneswaran A, Ayearst R, Haroon N, Inman RD. Fatigue in Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis: Analysis from a Longitudinal Observation Cohort. J Rheumatol. 2015 Dec 1;42(12):2354-60. Coauthor or Collaborator.

  • Bedaiwi MK, Sari I, Wallis D, O’Shea FD, Salonen D, Haroon N, Omar A, Inman RD. Celecoxib demonstrates clinical efficacy superior to acetaminophen in chronic nonspecific low back pain: Results of a randomized controlled trial. Arthritis Care Res (Hoboken). 2015 Oct 16;Epub. Coauthor or Collaborator.

  • Ward MM, Deodhar A, Akl EA, Lui A, Ermann J, Gensler LS, Smith JA, Borenstein D, Hiratzka J, Weiss PF, Inman RD, Majithia V, Haroon N, Maksymowych WP, Joyce J, Clark BM, Colbert RA, Figgie MP, Hallegua DS, Prete PE, Rosenbaum JT, Stebulis JA, van den Bosch F, Yu DT, Miller AS, Reveille JD, Caplan L. American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis. Arthritis Care Res (Hoboken). 2015 Sep 24;Epub. Coauthor or Collaborator.

  • Ward MM, Deodhar A, Akl EA, Lui A, Ermann J, Gensler LS, Smith JA, Borenstein D, Hiratzka J, Weiss PF, Inman RD, Majithia V, Haroon N, Maksymowych WP, Joyce J, Clark BM, Colbert RA, Figgie MP, Hallegua DS, Prete PE, Rosenbaum JT, Stebulis JA, van den Bosch F, Yu DT, Miller AS, Reveille JD, Caplan L. American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis. Arthritis Rheumatol. 2015 Sep 24;Epub. Coauthor or Collaborator.

  • Haroon N. Does a positive HLA-B27 test increase your risk of mortality? J Rheumatol. 2015;42(4):559-60. Principal Author.

  • Haroon NN, Paterson JM, Li P, Inman RD, Haroon N. Patients with ankylosing spondylitis have increased cardiovascular and cerebrovascular mortality: a population-based study. Annals of Internal Medicine. 2015 Sep 15;163(6):409-16. Senior Responsible Author.

  • Kenna TJ, Robinson PC, Haroon N. Endoplasmic reticulum aminopeptidases in the pathogenesis of ankylosing spondylitis. Rheumatology (Oxford). 2015 Sep 1;54(9):1549-56. Senior Responsible Author.

  • Robinson PC, Costello ME, Leo P, Bradbury LA, Hollis K, Cortes A, Lee S, Joo KB, Shim SC, Weisman M, Ward M, Zhou X, Garchon HJ, Chiocchia G, Nossent J, Lie BA, Førre Ø, Tuomilehto J, Laiho K, Jiang L, Liu Y, Wu X, Elewaut D, Burgos-Vargas R, Gensler LS, Stebbings S, Haroon N, Mulero J, Fernandez-Sueiro JL, Gonzalez-Gay MA, Lopez-Larrea C, Bowness P, Gafney K, Gaston JS, Gladman DD, Rahman P, Maksymowych WP, Xu H, van der Horst-Bruinsma IE, Chou CT, Valle-Oñate R, Romero-Sánchez MC, Hansen IM, Pimentel-Santos FM, Inman RD, Martin J, Breban M, Evans D, Reveille JD, Kim TH, Wordsworth BP, Brown MA. ERAP2 is associated with ankylosing spondylitis in HLA-B27-positive and HLA-B27-negative patients. Ann Rheum Dis. 2015 Aug 1;74(8):1627-9. Coauthor or Collaborator.

  • Abdullah H, Zhang Z, Yee K, Haroon N. KIR3DL1 interaction with HLA-B27 is altered by ankylosing spondylitis associated ERAP1 and enhanced by MHC class I cross-linking. Discov Med. 2015 Jul 1;20(108):79-89 (Trainee publication). Senior Responsible Author.

  • Haroon N. Ankylosis in ankylosing spondylitis: current concepts. Clin Rheumatol. 2015 Jun 1;34(6):1003-7. Principal Author.

  • Cortes A, Pulit SL, Leo PJ, Pointon JJ, Robinson PC, Weisman MH, Ward M, Gensler LS, Zhou X, Garchon HJ, Chiocchia G, Nossent J, Lie BA, Førre Ø, Tuomilehto J, Laiho K, Bradbury LA, Elewaut D, Burgos-Vargas R, Stebbings S, Appleton L, Farrah C, Lau J, Haroon N, Mulero J, Blanco FJ, Gonzalez-Gay MA, Lopez-Larrea C, Bowness P, Gaffney K, Gaston H, Gladman DD, Rahman P, Maksymowych WP, Crusius JB, van der Horst-Bruinsma IE, Valle-Oñate R, Romero-Sánchez C, Hansen IM, Pimentel-Santos FM, Inman RD, Martin J, Breban M, Wordsworth BP, Reveille JD, Evans DM, de Bakker PI, Brown MA. Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1. Nat Commun. 2015 May 21;6:7146. Coauthor or Collaborator.

  • Haroon N, Danda D. ‘Bamboo spine’, a thing of the past? Int J Rheum Dis. 2014 Feb 1;17(2):127-30. Principal Author.

  • Darren D. O’Rielly, Mohammed Uddin, Dianne Codner, Michael Hayley, Jiayi Zhou, Lourdes Pena-Castillo, Ahmed A. Mostafa, S.M. Mahmudul Hasan, William Liu, Nigil Haroon, Inman, Proton Rahman. Private rare deletions in SEC16A and MAMDC4 may represent novel
pathogenic variants in familial axial spondyloarthritis. Annals of Rheumatic Diseases. 2015 May 8;Epub:2014-206484. Coauthor or Collaborator.

  • Rohekar S, Chan J, Tse SM, Haroon N, Chandran V, Bessette L, Mosher D, Flanagan C, Keen KJ, Adams K, Mallinson M, Thorne C, Rahman P, Gladman DD, Inman RD. 2014 Update of the Canadian Rheumatology Association/Spondyloarthritis Research Consortium of Canada Treatment Recommendations for the Management of Spondyloarthritis. Part II: Specific Management Recommendations. J Rheumatol. 2015 Apr 15;42(4):665-81. Coauthor or Collaborator.

  • Rohekar S, Chan J, Tse SM, Haroon N, Chandran V, Bessette L, Mosher D, Flanagan C, Keen KJ, Adams K, Mallinson M, Thorne C, Rahman P, Gladman DD, Inman RD. 2014 Update of the Canadian Rheumatology Association/Spondyloarthritis Research Consortium of Canada Treatment Recommendations for the Management of Spondyloarthritis. Part I: Principles of the Management of Spondyloarthritis in Canada. J Rheumatol. 2015 Apr;42(4):654-64. Coauthor or Collaborator.

  • Chow S, Haroon N. A 24-year-old man with suspected sacroiliitis. CMAJ. 2015 Feb 3;187(2):124-5. Senior Responsible Author.

  • Robinson PC, Claushuis TA, Cortes A, Martin TM, Evans DM, Leo P, Mukhopadhyay P, Bradbury LA, Cremin K, Harris J, Maksymowych WP, Inman RD, Rahman P, Haroon N, Gensler L, Powell JE, van der Horst-Bruinsma IE, Hewitt AW, Craig JE, Lim LL, Wakefield D, McCluskey P, Voigt V, Fleming P, Spondyloarthritis Research Consortium of Canada, Australio-Anglo-American Spondylitis Consortium, International Genetics of Ankylosing Spondylitis Consortium, Wellcome Trust Case Control Study 2, Degli-Esposti M, Pointon JJ, Weisman MH, Wordsworth BP, Reveille JD, Rosenbaum JT, Brown MA. Genetic dissection of acute anterior uveitis reveals similarities and differences in associations observed with ankylosing spondylitis. Arthritis Rheumatol. 2015 Jan 1;67(1):140-51. Coauthor or Collaborator.

  • Wallis D, Thavaneswaran A, Haroon N, Ayearst R, Inman RD. Tumour necrosis factor inhibitor therapy and infection risk in axial spondyloarthritis: results from a longitudinal observational cohort. Rheumatology (Oxford). 2015 Jan 1;54(1):152-6. Coauthor or Collaborator.

  • Haroon NN, Paterson JM, Li P, Haroon N. Increasing proportion of female patients with ankylosing spondylitis: a population-based study of trends in the incidence and prevalence of AS. BMJ Open. 2014 Dec 15;4(12):e006634. Senior Responsible Author.

  • Lories RJ, Haroon N. Bone formation in axial spondyloarthritis. Best Pract Res Clin Rheumatol. 2014 Oct 1;28(5):765-77. Co-Principal Author.

  • Haroon N. The effect of tumor necrosis factor-blockade on new bone formation in ankylosing spondylitis: what is the evidence? Curr Opin Rheumatol. 2014 Jul 1;26(4):389-94. Principal Author.

  • Mahendira D, Thavaneswaran A, Carty A, Haroon N, Anton A, Passalent L, Alnaqbi KA, Savage L, Aslanyan E, Inman RD. Analysis of the effect of the oral contraceptive pill on clinical outcomes in women with ankylosing spondylitis. J Rheumatol. 2014 Jul 1;41(7):1344-8. Coauthor or Collaborator.

  • Tsui FW, Tsui HW, Akram A, Haroon N, Inman RD. The genetic basis of ankylosing spondylitis: new insights into disease pathogenesis. Appl Clin Genet. 2014 Jul 1;7:105-15. Coauthor or Collaborator.

  • Gracey E, Haroon n., Inman RD. HLA-B27, cytokines and Spondyloarthritis: Non-canonical functions of a curious class I MHC. Arthritis and Rheumatology. 2013 Dec 24;66(4):783-5. Impact Factor 7.477. Coauthor or Collaborator.

  • Wallis D, Haroon N, Ayearst R, Carty A, Inman RD. Ankylosing spondylitis and nonradiographic axial spondyloarthritis: part of a common spectrum or distinct diseases? Journal of Rheumatology. 2013 Dec;40(12):2038-41. Coauthor or Collaborator.

  • Wallis D, Asaduzzaman A, Weisman M, Haroon N, Anton A, McGovern D, Targan S, Inman R. Elevated serum anti-flagellin antibodies implicate subclinical bowel inflammation in ankylosing spondylitis: an observational study. Arthritis Research and Therapy. 2013 Oct 26;15(5):R166. Coauthor or Collaborator.

  • Maksymowych WP, Learch T, Lambert RG, Ward M, Haroon N, Inman R, Salonen D, Gensler LS, Weisman MH. Development and validation of the spondyloarthritis radiography module for calibration of readers using the modified stoke ankylosing spine score. Arthritis Care ad Research. 2013 Aug 7;66(1):55-62. Impact Factor 3.73. Coauthor or Collaborator.

  • Haroon N, Inman RD, Learch TJ, Weisman MH, Lee M, Rahbar MH, Ward MM, Reveille JD, Gensler LS. The Impact of TNF-inhibitors on radiographic progression in Ankylosing Spondylitis. Arthritis and Rheumatology. 2013 Jul 1;65(10):2645-54. Impact Factor 7.477. Principal Author.

  • International Genetics of Ankylosing Spondylitis Consortium (IGAS). Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci. Nature Genetics. 2013 Jun 9;45(7):730-8. Impact Factor 35.209. Coauthor or Collaborator.

  • Haroon N, Kim TH, Inman RD. NSAIDs and radiographic progression in ankylosing spondylitis Bagging big game with small arms? Annals of Rheumatic Diseases. 2012 Oct 7;71(10):1593-5. Impact Factor 9.11. Principal Author.

  • Prasad S; Misra R; Aggarwal A; Lawrence A; Haroon N; Krishnani N; Agrawal V; Paliwal V; Jha S; Agarwal V. Leprosy revealed in a rheumatology clinic: A case series. . International Journal of Rheumatic Diseases. International Journal of Rheumatic Diseases. 2012 doi: 10.1111/j.1756-185X.2012.01819.x. Coauthor or Collaborator.

  • Haroon N. Endoplasmic Reticulum Aminopeptidase 1 and Interleukin-23 Receptor in ankylosing spondylitis. Curr Rheumatol Rep. 2012;14(5):383-9. Principal Author.

  • Haroon N, Tsui FW, Uchanska-Ziegler B, Ziegler A and Inman RD. Endoplasmic Reticulum Aminopeptidase 1 (ERAP1) has functionally significant interaction with HLA B27 and dictates subtype specificity in ankylosing spondylitis. Ann Rheum Dis. 2012;71(4):589-95. Impact Factor 9.11. Principal Author.

  • Haroon N, Maksymowych WP, Rahman P, Tsui FWL, O’shea FD and Inman RD. Radiographic severity in ankylosing spondylitis is associated with polymorphism in Large Multifunctional Peptidase 2 (LMP2) in the SPARCC cohort. Arthritis Rheum. 2012;64(4):1119-26. Impact Factor 7.866. Principal Author.

  • Las Heras F, DaCosta RS, Pritzker KPH, Haroon N, Netchev G, Tsui HW, Chiu B, Tsui FWL Inman RD. Aberrant axial mineralization precedes spinal ankylosis: a molecular imaging study in /ank/ank/ mice. Arthritis Res Ther. 2011 Sep;13(5):R163. Coauthor or Collaborator.

  • Lui NL, Carty A, Haroon N, Shen H, Cook RJ, Inman RD. Clinical Correlates of Urolithiasis in Ankylosing Spondylitis. J Rheumatol. 2011 Jun;38(9):1953-6.

  • Lui NL, Haroon N, Carty A, Shen H, Cook RJ, Shanmugarajah S, Gladman DD, Inman RD. The Impact of Pregnancy on Ankylosing Spondylitis: a Case-Control Study. J Rheumatol. 2011;38(11):2442-4. Coauthor or Collaborator.

  • Haroon N and Inman RD. Endoplasmic reticulum aminopeptidases: biology and pathogenic potential. Nat Rev Rheumatol. 2010 Aug;6(8):461-7.

  • Haroon N, Inman RD. Ankylosing spondylitis – new criteria, new treatments. Bull NYU Hosp Jt Dis.

  • Haroon N. MRI in ankylosing spondylitis: To be or not to be. Indian Journal of Rheumatology. 2010;5(4):185-92.

  • Haroon N, Tsui FWL, Chiu B, Tsui HW, Inman RD. Serum cytokine receptors in ankylosing spondylitis: Relationship to inflammatory markers and endoplasmic reticulum aminopeptidase polymorphisms. J Rheum. 2010;37(9):1907-10.

  • Haroon N, Inman RD. Infectious complications of biologic therapy. Curr Opin Rheumatol. 2009 Jul;21(4):397-11.

  • Tsui FW, Haroon N, Reveille JD, Rahman P, Chiu B, Tsui HW, Inman RD. Association of an ERAP1 ERAP2 haplotype with familial ankylosing spondylitis. Ann Rheum Dis. 2009 69(4):733-6.

  • O’Shea FD, Haroon N, Salonen DC, Inman RD. Clinical and radiographic response to a local infliximab injection in a patient with chronic sacroiliitis. Nat Clin Pract Rheumatol. 2009;5:171-3.

  • Haroon N, O’Shea FD, Salonen D, Inman RD. Acetabular labral tear mimicking seronegative arthritis in a young male. Arthritis Rheum. 2009;61(6):850-2.

  • Haroon N, Srivastava R, Misra R, Aggarwal A. A novel predictor of clinical response to methotrexate in patients with rheumatoid arthritis: a pilot study of in vitro T-cell cytokine suppression assay. J Rheumatol. 2008;35:975-8.

  • Haroon N, Misra R, Aggarwal A. Tailor-made therapy in rheumatoid arthritis: fact or fiction? Isr Med Assoc J. 2008;10(2):139-41.

  • Haroon N, Tsui FWL, O’Shea FD, Chiu B, Tsui HW, Zhang H, Marshall KW, Inman RD. From gene expression to serum proteins: biomarker discovery in AS. Ann Rheum Dis. 2008. Epub ahead of print. Research article.

  • Haroon N, Aggarwal A, Lawrence A, Agarwal V, Misra R. Impact of rheumatoid arthritis on quality of life. Modern Rheumatol. 2007;17(4):290-5.

  • Haroon N. Better mental health scores in Indian patients with rheumatoid arthritis: what lies beneath? Natl Med J India. 2007;20(2):103.

  • Dhir V, Shukla S, Haroon N, Chowhan AK, Aggarwal A. Medical image. Arthritis and macroglossia. Multiple myeloma complicated by amyloidosis causing arthropathy. N Z Med J. 2007;120(1254):U2534.

  • Haroon N, Agarwal V, Aggarwal A, Kumari N, Krishnani N, Misra R. Pure neuritic leprosy: a rheumatologist’s dilemma. Rheumatology (Oxford). 2007;46:653-6.

  • Haroon N, Aggarwal A. Intramuscular cavernous hemangioma with juxta articular swelling. CMAJ. 2006;175(9):1059.

  • Haroon N, Aggarwal A, Garg N, Krishnani N, Kumari N, Agarwal V. An unusual case of systemic lupus erythematosus mimic: Disseminated gastric signet ring cell carcinoma. Indian J Med Sci. 2006;60(12):520-2.

  • Chandran V, Upadhyaya SK, Haroon N, Aggarwal A, Misra R. Lack of clinical association with antibodies to ribosomal P proteins in Indian patients with Systemic Lupus Erythematosus. J Rheumatol. 2006; 33(10):1987-9.

  • Bharadwaj A, Haroon N. Interstitial lung disease and neuropathy as predominant extra-articular manifestations in patients with rheumatoid arthritis: a prospective study. Med Sci Monit. 2005 Oct;11(10):CR498-502.

  • Haroon N, Nisha RS, Chandran V, Bharadwaj A. Pulmonary hypertension not a major feature of early mixed connective tissue disease: A prospective clinicoserological study. J Postgrad Med. 2005;51(2):104-8.

  • Haroon N, Amichandwala K and Solu MG. Comparative efficacy of quinine and artesunate in the treatment of severe malaria: A randomized controlled trial. JK Science. 2005; 7:32-35.

  • Bharadwaj A, Haroon N. Peripheral Neuropathy in patients on Leflunomide. Rheumatology (Oxford). 2004 Jul;43(7):934.

  • Chavda RK, Srivastava VS, Jain R, Haroon N, Ghia D. Management of severe and complicated malaria. The Indian Practitioner. 2002; 55(7):450-9.